cariporide has been researched along with 3',4'-dichlorobenzamil in 1 studies
| Studies (cariporide) | Trials (cariporide) | Recent Studies (post-2010) (cariporide) | Studies (3',4'-dichlorobenzamil) | Trials (3',4'-dichlorobenzamil) | Recent Studies (post-2010) (3',4'-dichlorobenzamil) |
|---|---|---|---|---|---|
| 409 | 10 | 79 | 94 | 0 | 4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carraway, KL; Chen, TY; Dunn, T; Floyd, C; Gorin, FA; Harley, W; Hegde, M; Leon, L; Lyeth, B; Nantz, MH; Palandoken, H; Zhang, XD | 1 |
1 other study(ies) available for cariporide and 3',4'-dichlorobenzamil
| Article | Year |
|---|---|
Dual inhibition of sodium-mediated proton and calcium efflux triggers non-apoptotic cell death in malignant gliomas.
Topics: Amiloride; Aniline Compounds; Animals; Astrocytes; Brain Neoplasms; Calcium; Cell Death; Cell Line, Tumor; Cytosol; Glioma; Guanidines; Humans; Hypoxia-Ischemia, Brain; Ionomycin; Ionophores; Personal Space; Phenyl Ethers; Protons; Rats; Rats, Sprague-Dawley; Sodium; Sodium-Calcium Exchanger; Sodium-Hydrogen Exchanger 1; Sodium-Hydrogen Exchangers; Sulfones; Tumor Microenvironment | 2010 |